Skip to main content

Hypertension in Women

Abstract

Cardiovascular disease remains the most common cause of death in women worldwide, with hypertension being the most common modifiable risk factor for cardiovascular disease in both sexes. Further, obesity plays a critical role in the development and management of hypertension with a disproportionate effect on minority women. Overall, gender specific differences in the pathogenesis and response to treatment of hypertension exist, and must be taken into consideration.

Keywords

  • Hypertension
  • Women
  • Cardiovascular disease

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-71135-5_3
  • Chapter length: 13 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-71135-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.00
Price excludes VAT (USA)
Hardcover Book
USD   149.00
Price excludes VAT (USA)

References

  1. Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008;29(1):3–22.

    CrossRef  PubMed  Google Scholar 

  2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  3. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  4. Ahmad A, Oparil S. Hypertension in women: recent advances and lingering questions. Hypertension. 2017;70(1):19–26.

    CrossRef  CAS  PubMed  Google Scholar 

  5. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013(133):1–8.

    Google Scholar 

  6. Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011-2014. NCHS Data Brief 2015(220):1–8.

    Google Scholar 

  7. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

    CrossRef  CAS  PubMed  Google Scholar 

  8. Collaborators GBDO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

    CrossRef  Google Scholar 

  9. An R. Prevalence and trends of adult obesity in the US, 1999-2012. ISRN Obes. 2014;2014:185132.

    PubMed  PubMed Central  Google Scholar 

  10. Hernandez DC, Reesor L, Murillo R. Gender disparities in the food insecurity-overweight and food insecurity-obesity paradox among low-income older adults. J Acad Nutr Diet. 2017;117(7):1087–96.

    CrossRef  PubMed  Google Scholar 

  11. Foundation TfAsHaRWJ. The state of obesity. Better policies for a healthier America 2017. Available from: http://stateofobesity.org/.

  12. Yancey AK, Cole BL, Brown R, Williams JD, Hillier A, Kline RS, et al. A cross-sectional prevalence study of ethnically targeted and general audience outdoor obesity-related advertising. Milbank Q. 2009;87(1):155–84.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  13. Sampson UK, Edwards TL, Jahangir E, Munro H, Wariboko M, Wassef MG, et al. Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study. Circ Cardiovasc Qual Outcomes. 2014;7(1):33–54.

    CrossRef  PubMed  Google Scholar 

  14. do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, de Lara Rodriguez CE, et al. Obesity-induced hypertension: brain signaling pathways. Curr Hypertens Rep. 2016;18(7):58.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  15. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991–1006.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.

    CrossRef  PubMed  Google Scholar 

  17. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57–70.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  18. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol. 2004;43(10):1817–22.

    CrossRef  PubMed  Google Scholar 

  19. Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.

    CrossRef  PubMed  Google Scholar 

  20. Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jorgensen T, et al. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project. PLoS One. 2014;9(9):e107294.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  21. Dallongeville J, Cottel D, Arveiler D, Tauber JP, Bingham A, Wagner A, et al. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab. 2004;48(1):43–50.

    CrossRef  CAS  PubMed  Google Scholar 

  22. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the study of women’s health across the nation. Arch Intern Med. 2008;168(14):1568–75.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  23. Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care. 2010;33(11):2457–61.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  24. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949–58.

    CrossRef  CAS  Google Scholar 

  25. Chandra A, Neeland IJ, Berry JD, Ayers CR, Rohatgi A, Das SR, et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol. 2014;64(10):997–1002.

    CrossRef  PubMed  Google Scholar 

  26. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, et al. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010;56(5):901–6.

    CrossRef  CAS  PubMed  Google Scholar 

  27. Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med. 1997;241(1):71–9.

    CrossRef  CAS  PubMed  Google Scholar 

  28. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011;58(5):784–90.

    CrossRef  CAS  PubMed  Google Scholar 

  29. Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:75–88.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  30. Kuznetsova T, Haddad F, Tikhonoff V, Kloch-Badelek M, Ryabikov A, Knez J, et al. Impact and pitfalls of scaling of left ventricular and atrial structure in population-based studies. J Hypertens. 2016;34(6):1186–94.

    CrossRef  CAS  PubMed  Google Scholar 

  31. Turkbey EB, McClelland RL, Kronmal RA, Burke GL, Bild DE, Tracy RP, et al. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging. 2010;3(3):266–74.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  32. Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol. 2006;47(11):2267–73.

    CrossRef  PubMed  Google Scholar 

  33. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens. 2002;20(2):323–31.

    CrossRef  PubMed  Google Scholar 

  34. De Simone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA, et al. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens. 2011;29(7):1431–8.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  35. Harlan SM, Rahmouni K. Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin. Clin Auton Res. 2013;23(1):1–7.

    CrossRef  PubMed  Google Scholar 

  36. da Silva AA, Hall JE, Moak SP, Browning J, Houghton HJ, Micheloni GC, et al. Role of autonomic nervous system in chronic CNS-mediated antidiabetic action of leptin. Am J Physiol Endocrinol Metab. 2017;312(5):E420–E8.

    CrossRef  PubMed  Google Scholar 

  37. Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol. 2013;305(6):R566–81.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  38. Xie D, Bollag WB. Obesity, hypertension and aldosterone: is leptin the link? J Endocrinol. 2016;230(1):F7–F11.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  39. Benetou V, Bamia C, Trichopoulos D, Mountokalakis T, Psaltopoulou T, Trichopoulou A. The association of body mass index and waist circumference with blood pressure depends on age and gender: a study of 10,928 non-smoking adults in the Greek EPIC cohort. Eur J Epidemiol. 2004;19(8):803–9.

    CrossRef  PubMed  Google Scholar 

  40. Chen Y, Rennie DC, Reeder BA. Age-related association between body mass index and blood pressure: the Humboldt Study. Int J Obes Relat Metab Disord. 1995;19(11):825–31.

    PubMed  CAS  Google Scholar 

  41. Uhernik AI, Milanovic SM. Anthropometric indices of obesity and hypertension in different age and gender groups of Croatian population. Coll Antropol. 2009;33(Suppl 1):75–80.

    PubMed  Google Scholar 

  42. Wakabayashi I. Relationships of body mass index with blood pressure and serum cholesterol concentrations at different ages. Aging Clin Exp Res. 2004;16(6):461–6.

    CrossRef  PubMed  Google Scholar 

  43. Pikilidou MI, Scuteri A, Morrell C, Lakatta EG. The burden of obesity on blood pressure is reduced in older persons: the SardiNIA study. Obesity (Silver Spring). 2013;21(1):E10–3.

    CrossRef  CAS  Google Scholar 

  44. Kagan A, Faibel H, Ben-Arie G, Granevitze Z, Rapoport J. Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J Hum Hypertens. 2007;21(2):128–34.

    CrossRef  CAS  PubMed  Google Scholar 

  45. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368–74.

    CrossRef  CAS  PubMed  Google Scholar 

  46. Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7.

    CrossRef  CAS  PubMed  Google Scholar 

  47. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25(8):1554–64.

    CrossRef  CAS  PubMed  Google Scholar 

  48. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55–61.

    CrossRef  CAS  PubMed  Google Scholar 

  49. Siu AL, Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86.

    CrossRef  PubMed  Google Scholar 

  50. Banegas JR, Segura J, de la Sierra A, Gorostidi M, Rodriguez-Artalejo F, Sobrino J, et al. Gender differences in office and ambulatory control of hypertension. Am J Med. 2008;121(12):1078–84.

    CrossRef  PubMed  Google Scholar 

  51. Divison-Garrote JA, Ruilope LM, de la Sierra A, de la Cruz JJ, Vinyoles E, Gorostidi M, et al. Magnitude of hypotension based on office and ambulatory blood pressure monitoring: results from a cohort of 5066 treated hypertensive patients aged 80 years and older. J Am Med Dir Assoc. 2017;18(5):452 e1–6.

    CrossRef  Google Scholar 

  52. Divison-Garrote JA, Banegas JR, De la Cruz JJ, Escobar-Cervantes C, De la Sierra A, Gorostidi M, et al. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives. J Am Soc Hypertens. 2016;10(9):714–23.

    CrossRef  PubMed  Google Scholar 

  53. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.

    CrossRef  CAS  PubMed  Google Scholar 

  54. Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67(4):693–700.

    CrossRef  CAS  PubMed  Google Scholar 

  55. Perez-Lloret S, Toblli JE, Cardinali DP, Milei J. Gender differences in age-related increase of asleep blood pressure. Arch Gerontol Geriatr. 2010;50(3):319–22.

    CrossRef  PubMed  Google Scholar 

  56. Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol. 2016;68(19):2033–43.

    CrossRef  PubMed  Google Scholar 

  57. Omboni S, Aristizabal D, De la Sierra A, Dolan E, Head G, Kahan T, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34(11):2187–98.

    CrossRef  CAS  PubMed  Google Scholar 

  58. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60(1):10–8.

    CrossRef  CAS  PubMed  Google Scholar 

  59. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation. 1998;98(18):1892–7.

    CrossRef  CAS  PubMed  Google Scholar 

  60. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139–44.

    CrossRef  CAS  PubMed  Google Scholar 

  61. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52–8.

    CrossRef  PubMed  Google Scholar 

  62. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54(2):226–32.

    CrossRef  CAS  PubMed  Google Scholar 

  63. Wang YC, Shimbo D, Muntner P, Moran AE, Krakoff LR, Schwartz JE. Prevalence of masked hypertension among US adults with nonelevated clinic blood pressure. Am J Epidemiol. 2017;185(3):194–202.

    PubMed  PubMed Central  Google Scholar 

  64. Peacock J, Diaz KM, Viera AJ, Schwartz JE, Shimbo D. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521–8.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  65. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–80.

    CrossRef  PubMed  Google Scholar 

  66. Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29(1 Pt 1):8–14.

    CrossRef  CAS  PubMed  Google Scholar 

  67. Thomas HN, Evans GW, Berlowitz DR, Chertow GM, Conroy MB, Foy CG, et al. Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT). J Hypertens. 2016;34(6):1224–31.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  68. Izumi Y, Matsumoto K, Ozawa Y, Kasamaki Y, Shinndo A, Ohta M, et al. Effect of age at menopause on blood pressure in postmenopausal women. Am J Hypertens. 2007;20(10):1045–50.

    CrossRef  PubMed  Google Scholar 

  69. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74(1):67–83.

    CrossRef  CAS  PubMed  Google Scholar 

  70. Bonnema RA, McNamara MC, Spencer AL. Contraception choices in women with underlying medical conditions. Am Fam Physician. 2010;82(6):621–8.

    PubMed  Google Scholar 

  71. Bulletins-Gynecology ACoP. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453–72.

    CrossRef  Google Scholar 

  72. American College of O, Gynecologists. ACOG Practice Bulletin No. 121: long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118(1):184–96.

    CrossRef  Google Scholar 

  73. Committee on Obstetric P. Committee Opinion No. 692: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2017;129(4):e90–e5.

    CrossRef  Google Scholar 

  74. Bokslag A, Teunissen PW, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216(5):523 e1–7.

    CrossRef  Google Scholar 

  75. Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, et al. All-cause and cause-specific mortality after hypertensive disease of pregnancy. Obstet Gynecol. 2016;128(2):238–44.

    CrossRef  PubMed Central  PubMed  Google Scholar 

  76. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.

    CrossRef  PubMed Central  CAS  PubMed  Google Scholar 

  77. Magee LA, Group CS, von Dadelszen P, Singer J, Lee T, Rey E, et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123(7):1143–51.

    CrossRef  CAS  PubMed  Google Scholar 

  78. Peacock WFT, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981–93.

    CrossRef  PubMed  Google Scholar 

  79. Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 2010;23(11):1234–40.

    CrossRef  CAS  PubMed  Google Scholar 

  80. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252.

    Google Scholar 

  81. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407–17.

    CrossRef  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amier Ahmad M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Ahmad, A., Oparil, S. (2018). Hypertension in Women. In: Mehta, J., McSweeney, J. (eds) Gender Differences in the Pathogenesis and Management of Heart Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-71135-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71135-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71134-8

  • Online ISBN: 978-3-319-71135-5

  • eBook Packages: MedicineMedicine (R0)